title: Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans.
abstract: Several genome-wide association studies identified the chr15q25.1 region, which includes three nicotinic cholinergic receptor genes (CHRNA5-B4) and the cell proliferation gene (PSMA4), for its association with lung cancer risk in Caucasians. A haplotype and its tagging single nucleotide polymorphisms (SNPs) encompassing six genes from IREB2 to CHRNB4 were most strongly associated with lung cancer risk (OR = 1.3; P < 10(-20)). In order to narrow the region of association and identify potential causal variations, we performed a fine-mapping study using 77 SNPs in a 194 kb segment of the 15q25.1 region in a sample of 448 African-American lung cancer cases and 611 controls. Four regions, two SNPs and two distinct haplotypes from sliding window analyses, were associated with lung cancer. CHRNA5 rs17486278 G had OR = 1.28, 95% CI 1.07-1.54 and P = 0.008, whereas CHRNB4 rs7178270 G had OR = 0.78, 95% CI 0.66-0.94 and P = 0.008 for lung cancer risk. Lung cancer associations remained significant after pack-year adjustment. Rs7178270 decreased lung cancer risk in women but not in men; gender interaction P = 0.009. For two SNPs (rs7168796 A/G and rs7164594 A/G) upstream of PSMA4, lung cancer risks for people with haplotypes GG and AA were reduced compared with those with AG (OR = 0.56, 95% CI 0.38-0.82; P = 0.003 and OR = 0.73, 95% CI 0.59-0.90, P = 0.004, respectively). A four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002). The identified regions contain SNPs predicted to affect gene regulation. There are multiple lung cancer risk loci in the 15q25.1 region in African-Americans.
authors.affiliation: Division of Neuroepidemiology, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
authors.forename: Helen M
authors.initials: HM
authors.lastname: Hansen
authors.forename: Yuanyuan
authors.initials: Y
authors.lastname: Xiao
authors.forename: Terri
authors.initials: T
authors.lastname: Rice
authors.forename: Paige M
authors.initials: PM
authors.lastname: Bracci
authors.forename: Margaret R
authors.initials: MR
authors.lastname: Wrensch
authors.forename: Jennette D
authors.initials: JD
authors.lastname: Sison
authors.forename: Jeffery S
authors.initials: JS
authors.lastname: Chang
authors.forename: Ivan V
authors.initials: IV
authors.lastname: Smirnov
authors.forename: Joseph
authors.initials: J
authors.lastname: Patoka
authors.forename: Michael F
authors.initials: MF
authors.lastname: Seldin
authors.forename: Charles P
authors.initials: CP
authors.lastname: Quesenberry
authors.forename: Karl T
authors.initials: KT
authors.lastname: Kelsey
authors.forename: John K
authors.initials: JK
authors.lastname: Wiencke
mesh_terms: D000293:Adolescent; D000328:Adult; D001741:Black or African American / Q000235:genetics*; D000368:Aged; D016022:Case-Control Studies; D002874:Chromosome Mapping; D002884:Chromosomes, Human, Pair 15 / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D011978:Receptors, Nicotinic / Q000235:genetics; D012907:Smoking / Q000235:genetics; D055815:Young Adult
chemical_list: D009419:Nerve Tissue Proteins; D011978:Receptors, Nicotinic; C447158:CHRNA5 protein, human